Phase III study of radiation therapy with or without cis-platinum in patients with unresectable squamous or undifferentiated carcinoma of the head and neck: an intergroup trial of the Eastern Cooperative Oncology Group (E2382).
about
A meta-analysis of weekly cisplatin versus three weekly cisplatin chemotherapy plus concurrent radiotherapy (CRT) for advanced head and neck cancer (HNC).Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data.Squamous cell carcinoma metastatic to cervical lymph nodes from unknown primary origin: the impact of chemoradiotherapy.In squamous cell head and neck cancer: which platinum, how much and how often?Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review.Pharmacotherapy of head and neck cancer.The impact of cumulative dose of cisplatin on outcome of patients with head and neck squamous cell carcinoma.Risk of swallowing-related chest infections in patients with nasopharyngeal carcinoma treated with definitive intensity-modulated radiotherapy.ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.Systemic therapy in the curative treatment of head and neck squamous cell cancer: a systematic review
P2860
Q36125036-D5F79D95-4D31-498F-AD20-39797CC66F16Q36378279-D50C0503-22ED-4D87-8CC2-3A78BDA0612EQ37183590-2ED26EF8-0998-4AD7-AEF3-B858960B12E2Q38226689-CF8CB931-25F7-4AA6-B5E3-F9EB5CF4E05FQ38367277-14E01A4C-9278-40F3-A66D-B7BFBFA320A9Q38619293-99831691-2592-4E47-97FF-0BA88D0D2826Q38654246-956E1651-4245-4735-8D96-7F132D2F115CQ38739241-378EE6E6-C8FC-4269-BF55-7C492C773E2CQ38850017-9B46CF8B-56FA-436C-BE40-1FA5F0FDB10CQ38855117-E97DBD29-EDEB-4523-9179-271C51CFF6CC
P2860
Phase III study of radiation therapy with or without cis-platinum in patients with unresectable squamous or undifferentiated carcinoma of the head and neck: an intergroup trial of the Eastern Cooperative Oncology Group (E2382).
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Phase III study of radiation t ...... rative Oncology Group (E2382).
@ast
Phase III study of radiation t ...... rative Oncology Group (E2382).
@en
type
label
Phase III study of radiation t ...... rative Oncology Group (E2382).
@ast
Phase III study of radiation t ...... rative Oncology Group (E2382).
@en
prefLabel
Phase III study of radiation t ...... rative Oncology Group (E2382).
@ast
Phase III study of radiation t ...... rative Oncology Group (E2382).
@en
P2093
P2860
P1476
Phase III study of radiation t ...... rative Oncology Group (E2382).
@en
P2093
Arlene Forastiere
Bruce Leipzig
Harry Quon
Jay Cooper
Robert Haselow
Traci Leong
P2860
P304
P356
10.1016/J.IJROBP.2010.06.038
P407
P577
2010-10-01T00:00:00Z